California Public Employees Retirement System lowered its position in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 13.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,988 shares of the medical instruments supplier’s stock after selling 3,459 shares during the quarter. California Public Employees Retirement System owned approximately 0.11% of ICU Medical worth $6,750,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. HPM Partners LLC acquired a new stake in shares of ICU Medical in the second quarter valued at approximately $288,000. Zacks Investment Management acquired a new stake in shares of ICU Medical in the second quarter valued at approximately $4,291,000. Paloma Partners Management Co increased its holdings in shares of ICU Medical by 1,815.5% in the second quarter. Paloma Partners Management Co now owns 48,099 shares of the medical instruments supplier’s stock valued at $14,124,000 after purchasing an additional 45,588 shares during the last quarter. Macquarie Group Ltd. acquired a new stake in shares of ICU Medical in the second quarter valued at approximately $411,000. Finally, Cubist Systematic Strategies LLC acquired a new stake in shares of ICU Medical in the second quarter valued at approximately $5,849,000. 74.29% of the stock is owned by institutional investors and hedge funds.
ICUI stock opened at $265.80 on Friday. The firm has a market cap of $5.79 billion, a price-to-earnings ratio of 47.73 and a beta of 0.41. ICU Medical, Incorporated has a 52-week low of $180.45 and a 52-week high of $321.70.
ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, August 9th. The medical instruments supplier reported $2.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.82 by $0.84. The company had revenue of $360.46 million during the quarter, compared to analysts’ expectations of $337.60 million. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.76 earnings per share. Equities analysts expect that ICU Medical, Incorporated will post 7.6 EPS for the current year.
Several equities research analysts recently commented on the company. Zacks Investment Research cut ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Thursday. ValuEngine raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 28th. Finally, TheStreet raised ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th. One investment analyst has rated the stock with a hold rating and two have issued a buy rating to the company. ICU Medical has a consensus rating of “Buy” and a consensus price target of $337.00.
In other ICU Medical news, Director Pfizer Inc sold 700,000 shares of the firm’s stock in a transaction on Monday, August 13th. The stock was sold at an average price of $284.35, for a total transaction of $199,045,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Virginia Ruth Sanzone sold 787 shares of the firm’s stock in a transaction on Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total value of $238,555.44. Following the sale, the vice president now directly owns 1,367 shares of the company’s stock, valued at approximately $414,365.04. The disclosure for this sale can be found here. In the last three months, insiders have sold 711,920 shares of company stock valued at $202,651,956. 12.50% of the stock is owned by insiders.
ICU Medical Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Read More: Hedge Funds
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.